Thermo Fisher is not just another PageGroup client with a shiny case study and a clean little hiring problem. It is a global science giant whose public record drags through Tibet, Xinjiang, DNA surveillance concerns, Henrietta Lacks, prison drug-test false positives, COVID test accuracy issues, antitrust interventions, controlled-substance recordkeeping and workplace safety citations. Michael Page says it had an ‘ongoing partnership’ with Thermo Fisher and helped it fill a difficult operations role. Lovely. Because when the company selling laboratory purity needs a recruiter to filter humans, TCAP has one question: who gets shortlisted, who gets quietly buried, and what kind of bastard machine is Page helping polish?

Welcome To The Cold Room

Some Page Partners hits smell like finance. Some smell like bribery. Some smell like consumer-brand sewage with a purpose statement poured over it.

Thermo Fisher smells different.

It smells clinical. Refrigerated. White tiles. Stainless steel. A humming freezer at the end of a corridor nobody wants to walk down.

This is not a minor client badge or a soft corporate hypocrisy piece. This is a company whose products, partnerships and public controversies sit near some of the darkest questions modern business can ask: who owns human biological data, who profits from bodies, who gets surveilled, who gets tested, who gets punished, who gets filtered, and who gets told the system is neutral while the door closes behind them.

And then there is Page.

Michael Page’s own case study says it had an ongoing partnership with Thermo Fisher. Page Executive had previously worked with Thermo Fisher’s Ashford site, and Michael Page Engineering & Manufacturing was brought in for a challenging Operations Manager search.

So this is PageGroup inside Thermo Fisher’s recruitment machinery.

Not Page Outsourcing, based on the public proof available. TCAP is not going to invent the wrong badge for convenience. The public source says Michael Page / PageGroup.

That is enough.

Because the product is the same: judgement, filtering, shortlisting, access to human beings.

And when Thermo Fisher is the client, that filter deserves a fucking autopsy.

The Page Connection

Michael Page’s Thermo Fisher case study is clean, calm and recruiter-smooth.

Thermo Fisher needed an Operations Manager for its Ashford site. The location was challenging for high-calibre engineering candidates. Page Executive had already worked with the site. Michael Page Engineering & Manufacturing stepped in.

That sounds ordinary enough until you remember what recruitment is.

Recruitment is not just names in a spreadsheet. It is access control. It is who gets called. Who gets encouraged. Who gets dropped. Who gets labelled complicated. Who gets a clean read. Who gets a risk note. Who gets quietly filtered out before the employer ever sees the whole human being.

In my case, Page’s conduct raises questions about discrimination complaint handling, redactions, DSAR disclosure, joinder, ET3 silence and what looked like a corporate attempt to bail out when the room got hot.

So when Michael Page advertises an ongoing partnership with Thermo Fisher, TCAP is not looking at the brochure.

TCAP is looking at the filter.

And this filter sits next to a company with a controversy file that looks like someone stored human rights in a lab freezer and forgot to label the fucking samples.

Tibet: DNA Kits In The Surveillance Fog

Start with Tibet.

The Congressional-Executive Commission on China wrote to Thermo Fisher in 2022 raising concerns that the company’s DNA kits and sequencer replacement parts had been sold directly to police in the Tibet Autonomous Region. The commissioners said they were concerned Thermo Fisher products could be used in mass DNA collection and could enable further gross human-rights violations.

That is not a customer-service complaint.

That is not a packaging defect.

That is not a lab coat with a coffee stain.

That is elected officials asking whether a US biotech giant’s products were sitting inside a state surveillance machine aimed at an occupied, heavily controlled population.

The CECC letter referred to Citizen Lab research estimating that police in Tibet collected roughly 900,000 to 1.2 million DNA samples between 2016 and 2022. That is roughly a quarter to a third of Tibet’s population.

A quarter to a third.

Imagine that as a recruitment funnel. Imagine that as a database. Imagine the quiet violence of turning a people into searchable material.

Thermo Fisher later stopped selling Human Identification products in Tibet. The company said it ceased those sales in mid-2023.

Good.

But TCAP has a simple problem with corporate morality that arrives after the pressure campaign, the congressional letters, the investor noise and the human-rights alarm bells.

If your ethics need a fucking searchlight, they are not ethics. They are damage control with a barcode.

Xinjiang: The Same Ghost, Different Freezer

Then there is Xinjiang.

Human Rights Watch reported in 2017 that Chinese authorities in Xinjiang were collecting DNA samples, fingerprints, iris scans and blood types from residents aged 12 to 65. HRW said follow-up research found that Thermo Fisher Scientific had supplied Xinjiang police with some of the DNA sequencers used in that infrastructure.

Thermo Fisher later said it would stop selling or servicing genetic sequencers in Xinjiang.

Again, good.

Again, late.

Again, after the stench had already reached the ventilation system.

Xinjiang is not some obscure compliance footnote. It is one of the central human-rights horror stories of the modern corporate age. Surveillance, detention, coercion, forced conformity, fear, data, ethnicity, policing, bodies.

And Thermo Fisher’s name appears in the public record around DNA technology in that ecosystem.

So when PageGroup wants to present Thermo Fisher as a neat client success story, TCAP is entitled to ask a very simple question.

What kind of people filter do you provide for a company whose products have been publicly linked to state DNA collection in Xinjiang and Tibet?

And what happens when a human being entering that recruitment process has a medical history, a disability, a complaint, a gap, or anything else that makes them less convenient than a sterile job spec?

The Research Paper That Went In The Bin

It gets colder.

The Guardian reported that an academic paper using blood and saliva samples from Uyghur and Kazakh people in Xinjiang was retracted over ethical concerns. The study evaluated genetic sequencing technology developed by Thermo Fisher Scientific.

The retraction notice said the relevant ethical approval had not been obtained for collection of the genetic samples.

That sentence should make the lights flicker.

Relevant ethical approval had not been obtained.

Human genetic material. Vulnerable populations. Xinjiang. Forensic genetics. Police-use implications. Thermo Fisher technology being evaluated.

This is where the corporate brochure starts to look like a toe tag.

Thermo Fisher can talk about science serving the world. Page can talk about talent solutions. Everyone can say innovation until the projector overheats.

But when the subject is DNA from Uyghur and Kazakh people in one of the most coercive environments on earth, the word ‘innovation’ starts sounding like someone whistling in a morgue.

AP’s Surveillance State File

The Associated Press later reported on the role of US technology firms in helping enable China’s digital police state, naming Thermo Fisher among companies whose technology included DNA sequencing used by police and security agencies.

That matters because it gives the Thermo Fisher story a wider frame.

Not one awkward contract.

Not one nasty regional issue.

A much broader picture of American technology feeding surveillance systems, while companies reach for the usual corporate rosary beads: export compliance, customer use, legal markets, values, policies, regret, review, blah blah fucking blah.

You know the hymn sheet.

They sell the tool. The state builds the cage. The company says it does not control the architecture. Then somebody asks about the blood on the instruction manual.

Henrietta Lacks: The Body That Kept Paying

Then we leave China and hit one of the most infamous bioethics stories in medical history.

Henrietta Lacks was a Black woman whose cells were taken without her consent in 1951. Her HeLa cells became one of the most important tools in modern medical research.

Her family sued Thermo Fisher, alleging the company profited from the use and sale of products involving those cells. Thermo Fisher settled the lawsuit in 2023 on confidential terms.

So add that to the cold room.

DNA surveillance concerns in Tibet.

DNA sequencers in Xinjiang.

Ethics concerns around Uyghur and Kazakh genetic research.

Then Henrietta Lacks.

A Black woman’s cells taken without consent, turned into a scientific engine, then the modern biotech economy gets to argue about who gets paid while the family carries the history.

There is no joke dark enough for that.

There is only anger.

And when PageGroup is helping Thermo Fisher find people, shortlist people and process people, TCAP is going to ask whether the same corporate instinct applies: the human being is sacred in the values statement, but useful material in the system.

Prison Drug Tests: False Positives And Solitary

Now add Microgenics, a Thermo Fisher subsidiary.

New York’s Inspector General investigated a prison drug-testing programme and found that more than 1,600 incarcerated people suffered sanctions after preliminary tests proved highly unreliable. The IG said 140 people were subjected to solitary confinement.

Solitary confinement.

Because of unreliable preliminary tests.

The Inspector General also said company representatives obstructed sanctioned people’s efforts to challenge results by providing false or misleading information in administrative hearings.

Read that again and let the corporate air leave the room.

False positives. Prison sanctions. Solitary. Misleading information. Human beings punished by a system that treated bad testing like truth and treated the people trapped inside it like disposable meat.

This is not abstract.

This is exactly why systems matter. Testing systems. Prison systems. Recruitment systems. Complaint systems. Redaction systems.

A bad system does not need to scream. It just needs a form, a result, a policy and a person with enough authority to say “next”.

That is where Page comes in.

Because recruitment filtering is also a system. And in my experience, Page’s system under challenge did not look like a clean temple of fairness. It looked like a fucking bunker with the lights off.

COVID Test Accuracy: The Clean Machine Coughs

During COVID, Thermo Fisher’s TaqPath test was one of the major commercial coronavirus tests.

FDA-linked reporting flagged issues that could lead to inaccurate results. One problem involved insufficient mixing and possible false positives. Another involved software interpretation problems that could lead to false negatives or inconclusive results.

This is not the main hit, but it belongs in the file.

Because Thermo Fisher was not selling scented candles. It was selling diagnostic machinery in a public-health emergency. People made decisions off tests. Institutions made decisions off tests. Workers, families, labs and hospitals lived inside the consequences.

When science companies get it wrong, the error does not stay in the lab.

It walks into homes, workplaces, prisons, hospitals, borders and bodies.

And that is why TCAP does not give a shit about glossy case studies when the underlying record has this much noise coming from the walls.

Controlled Substances: The Recordkeeping Corpse

Then there is the Controlled Substances Act settlement.

In 2022, Thermo Fisher Scientific Chemicals agreed to pay $25,000 to resolve allegations that it violated the Controlled Substances Act by improperly purchasing and distributing regulated chemicals. The company self-disclosed. The settlement said it failed to file export declarations for listed chemicals to foreign customers, distributed listed chemicals to a Thermo Fisher location without appropriate DEA registrations, and purchased listed chemicals from suppliers without appropriate DEA registrations.

That is not the biggest scandal in the file.

But it is another little leak in the laboratory ceiling.

Chemicals that can be used to manufacture controlled substances require tight records for a reason. When the company selling scientific discipline gets caught on recordkeeping, TCAP is not going to clap because it self-disclosed.

We are going to write it down, put it in the freezer drawer with the rest, and ask why the company of precision keeps appearing in stories where the paperwork matters after the fucking problem has already happened.

Antitrust: Science Market, Same Old Corporate Appetite

Thermo Fisher also has antitrust baggage.

The FTC put conditions on Thermo Fisher’s $13.6 billion acquisition of Life Technologies, alleging the deal as originally proposed would likely substantially lessen competition in markets including siRNA reagents, cell culture media and cell culture sera. Thermo Fisher had to divest assets.

Earlier, the FTC charged that Thermo Electron’s proposed acquisition of Fisher Scientific would harm competition in the US market for high-performance centrifugal vacuum evaporators. The FTC said Thermo and Fisher were the only two significant suppliers in that market and required divestiture of Fisher’s Genevac business.

That is the polite regulatory language.

The TCAP translation is simpler: even in the world of science kit, the corporate appetite still turns up with a bib around its neck.

Buy the rival. Consolidate the market. Reduce competition. Smile through the consent order. Call it growth. Call it strategy. Call it whatever the fuck you like.

The body count is competition, pricing, access and innovation.

Same old capitalism. Cleaner lab coat.

Workplace Safety: The Forklift In The Flammable Room

There are also OSHA records.

One OSHA record shows a repeat powered-industrial-truck citation involving a Thermo Fisher site in Haverhill, Massachusetts, where an industrial truck was permitted to operate within a flammable liquids warehouse and shipping and receiving areas. Another 2024 OSHA record concerns powered-industrial-truck modifications affecting safe operation. Another 2022 record concerns hazardous storage exposing employees to struck-by and falling-object hazards.

Again, this is not the Tibet file.

But it matters.

Because Page Partners is about people. Workers. Candidates. Applicants. Humans passing through corporate machinery while the brochure says values and the floor says watch your head.

Thermo Fisher sells precision. OSHA records talk about hazards.

Thermo Fisher sells science. Workers still have to move through warehouses, trucks, storage areas and risk.

Page sells recruitment judgement. Candidates still have to move through filters they cannot see.

Different machine. Same question.

Who gets protected, and who gets processed?

Wage And Break Claims

There is more.

A California wage-and-hour class-action settlement reportedly resolved claims that Thermo Fisher failed to provide sufficient wage, meal and rest breaks, failed to pay for all hours worked, failed to pay overtime and violated California labour law.

Thermo Fisher did not become evil because of one employment settlement. That is not the argument.

The argument is accumulation.

Tibet. Xinjiang. Genetic research ethics. Henrietta Lacks. Prison false positives. COVID test accuracy warnings. Controlled-substance recordkeeping. Antitrust. OSHA. Wage and break claims.

At some point, the file stops looking like isolated incidents and starts looking like a corporate anatomy chart with pins in it.

And PageGroup is there, smiling from the recruitment case study, talking about partnership and high-calibre candidates like the room is not already full of ghosts.

The Recruitment Filter

This is the core.

Michael Page says Thermo Fisher had an ongoing partnership and that Page helped with a difficult operations hire. That means Page was involved in filtering candidates for a company sitting on this public record.

So TCAP asks the questions Page and Thermo Fisher would rather leave in a drawer.

What does Page do with disabled candidates?

What does Page do with health-related work gaps?

What does Page do when a candidate raises discrimination?

What does Page do when the human being is messy, inconvenient, medically complicated, unemployed, angry, traumatised or unwilling to be processed like clean data?

Because Thermo Fisher’s controversies are not random to this series. They all orbit the same black star: systems that turn people into material.

DNA samples. Cell lines. prison test results. COVID test outputs. candidate profiles. labour-market records. shortlists. complaint files. DSAR redactions.

The corporate machine loves humans most when they are reduced to data it can move, sell, test, screen, reject, silence or deny.

And Page’s job is filtering humans.

That is why this one matters.

Page Partner Protection

In my case, Page was joined to Employment Tribunal proceedings because its role in the recruitment chain mattered. Then came the silence, the distancing and the attempted bail-out.

That is Page Partner Protection.

Protection for the commercial relationship. Protection for the client badge. Protection for the recruitment machine. Protection for the glossy bit.

Not protection for the candidate.

Not protection for the disabled applicant.

Not protection for the person asking why the paperwork looks like it went through a shredder with a guilty conscience.

So when PageGroup helps Thermo Fisher recruit, TCAP is entitled to ask whether the same instinct applies.

When the machine is challenged, does it explain itself?

Or does it go quiet, close ranks and wait for the inconvenient human to run out of oxygen?

The Question For Thermo Fisher

So here it is.

Did Thermo Fisher ask Michael Page how it handles disability-related complaints from candidates? Did it ask how Page treats health-related employment gaps? Did it ask what Page does when a disabled applicant challenges the process? Did it ask whether Page’s recruitment judgement matches the values Thermo Fisher claims to apply to its own science, ethics and people?

Or did Thermo Fisher simply need a shortlist and decide not to look too closely at the filter?

Because this is a company that should understand the danger of bad systems. Bad sampling systems. Bad testing systems. Bad consent systems. Bad surveillance systems. Bad recordkeeping systems. Bad workplace safety systems.

Recruitment is a system too.

And when a company with Thermo Fisher’s record buys candidate judgement from Page, TCAP is going to ask what happens to the candidates who do not fit neatly into the vial.

The Page Partners Verdict

Thermo Fisher is one of the strongest Page Partners targets because the darkness is not decorative. It is structural.

This is not just a company with one old fine and a tired apology. This is a science giant whose public controversy file touches mass DNA collection concerns in Tibet and Xinjiang, vulnerable ethnic groups, genetic research ethics, Henrietta Lacks, prison false positives, solitary confinement, COVID test accuracy warnings, controlled-substance recordkeeping, antitrust conditions, OSHA citations and wage-and-hour claims.

Then Michael Page turns up with the recruitment case study.

Ongoing partnership.

Difficult operations hire.

High-calibre candidates.

Shortlist.

There is the whole rotten picture.

A company built on precision, with a record full of human consequences, using a recruiter whose own conduct in my case raises questions about discrimination, disclosure and silence.

Page sells the filter.

Thermo Fisher buys the filter.

TCAP opens the filter and asks what kind of human material gets left inside.

Because when your client’s file already smells of DNA surveillance, prison punishment, stolen cells, bad tests, market consolidation and workplace hazards, the recruitment brochure does not look clean.

It looks like a white coat hanging on a meat hook.

And PageGroup is standing underneath it, smiling, clipboard in hand, pretending the blood on the floor is just another data point.

Lee Thompson – Founder, The Cummins Accountability Project

Page Partners : Thermo Fisher – The Recruitment Filter And The DNA Surveillance Crypt